Ishan Roy, Ph.D.
Affiliations: | 2014 | Medical College of Wisconsin, Milwaukee, WI, United States |
Area:
Microbiology Biology, Ecology Biology, Molecular BiologyGoogle:
"Ishan Roy"Parents
Sign in to add mentor| Michael Dwindl | grad student | 2014 | Medical College of Wisconsin | |
| (Roles for chemokines in pancreatic cancer metastasis.) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Vonderhaar E, Dwinell M, Roy IR, et al. (2018) 2543 High concentrations of CXCL12 decrease pancreatic adenocarcinoma growth Journal of Clinical and Translational Science. 2: 13-14 |
| Ziarek JJ, Kleist AB, London N, et al. (2017) Structural basis for chemokine recognition by a G protein-coupled receptor and implications for receptor activation. Science Signaling. 10 |
| Roy I, Boyle KA, Vonderhaar EP, et al. (2017) Cancer cell chemokines direct chemotaxis of activated stellate cells in pancreatic ductal adenocarcinoma. Laboratory Investigation; a Journal of Technical Methods and Pathology |
| Roy I, Getschman AE, Volkman BF, et al. (2016) Exploiting agonist biased signaling of chemokines to target cancer. Molecular Carcinogenesis |
| Roy I, Boyle KA, Mackinnon AC, et al. (2016) Abstract A21: Chemokine directed migration of activated stellate cells in pancreatic ductal adenocarcinoma Cancer Research. 76 |
| Roy I, McAllister DM, Gorse E, et al. (2015) Pancreatic Cancer Cell Migration and Metastasis Is Regulated by Chemokine-Biased Agonism and Bioenergetic Signaling. Cancer Research. 75: 3529-42 |
| Zimmerman NP, Roy I, Hauser AD, et al. (2015) Cyclic AMP regulates the migration and invasion potential of human pancreatic cancer cells. Molecular Carcinogenesis. 54: 203-15 |
| Roy I, McAllister D, Gorse E, et al. (2015) Abstract B55: Chemokine biased agonists regulate pancreatic cancer migration and metastasis through bioenergetic signaling Cancer Research. 75 |
| Flister MJ, Endres BT, Rudemiller N, et al. (2014) CXM: a new tool for mapping breast cancer risk in the tumor microenvironment. Cancer Research. 74: 6419-29 |
| Roy I, Evans DB, Dwinell MB. (2014) Chemokines and chemokine receptors: update on utility and challenges for the clinician. Surgery. 155: 961-73 |